Evolent Health, Inc. (EVH)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Evolent Health, Inc. reported revenue of $1.88B, down 26.6% from the prior year. The company ran a net loss, with a net margin of -28.5%. It held $1.90B in total assets against $1.48B in total liabilities.
Key ratios (FY2025)
-21.9%
Operating margin
-28.5%
Net margin
-128.7%
Return on equity
-26.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $907.96M | $924.64M | $846.38M | $627.06M | $434.95M | $254.19M |
| Cost of Revenue | $1.48B | $2.19B | $1.50B | $1.04B | $657.55M | — | — | — | — | — |
| Operating Income | -$410.14M | -$40.48M | -$71.21M | $3.64M | -$42.41M | -$262.85M | -$308.88M | -$47.48M | -$72.84M | -$237.42M |
| Net Income | -$534.51M | -$61.62M | -$113.04M | -$19.16M | -$37.60M | -$334.25M | -$301.97M | -$52.66M | -$60.66M | -$159.74M |
| EPS (Diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 | $-3.94 | $-3.67 | — | $-0.94 | $-3.55 |
| Total Assets | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B | $1.37B | $1.50B | $1.72B | $1.31B | $1.20B |
| Total Liabilities | $1.48B | $1.35B | $1.43B | $957.88M | $725.83M | $752.10M | $568.97M | $532.92M | $266.39M | $287.73M |
| Shareholders' Equity | $415.19M | $1.00B | $1.07B | $859.42M | $693.63M | $619.60M | $929.05M | $1.14B | $1.01B | $702.53M |
| Cash & Equivalents | $151.86M | $104.20M | $192.82M | $188.20M | $266.28M | $319.00M | $101.01M | $228.32M | $238.43M | $134.56M |
| Operating Cash Flow | $38.84M | $18.77M | $142.58M | -$11.55M | $38.75M | -$16.23M | -$42.65M | -$20.65M | -$27.96M | -$35.51M |
| Capital Expenditures | — | — | — | — | — | — | $35.53M | $39.55M | $27.85M | $15.53M |
| Shares Outstanding | 114.21M | 114.68M | 111.25M | 93.70M | 86.07M | 84.93M | 82.36M | — | 64.35M | 45.03M |